ZY

Cathie Wood Loaded Up on Zymergen (ZY) Stock Before Ginkgo Buyout

By Bret Kenwell, InvestorPlace Contributor
Zymergen shares are rallying after an all-stock buyout from Ginkgo Bioworks. Cathie Wood's Ark owns both DNA shares and ZY stock.

Zymergen (ZY) Stock Soars 20% on Acquisition News

By Josh Enomoto, InvestorPlace Contributor
Zymergen finally received some much-needed good news when Ginkgo Bioworks agreed to buy out the firm, sending ZY stock soaring.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer
Good morning, investors! Busy traders are already at work this morning as we go over the biggest pre-market stock movers for Wednesday.

ZY Stock: Zymergen Plunges After Calling for No Product Revenue in 2021. Here’s Why.

By Robert Lakin, InvestorPlace Contributor
Zymergen reaffirmed product pipeline expectations in May. But ZY stock investors just received the bad news that the guidance no longer holds.

7 Best Tech Stocks Pumped Out by Softbank’s ‘Golden Egg’ Machine

By Alex Sirois, InvestorPlace Contributor
Tech stocks are on display in Softbank's Vision Fund. These seven are among the best ones, now public, to consider investing in.